StockData
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (ACRS) stock

ACRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30138% above fair value
$3.50+0.12 (+3.55%)

Close on Nov 18, 2026Market cap $515.20MP/E –Yield –

Aclaris Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aclaris Therapeutics's market cap was $606.84M on Nov 11, 2026, against $306.61M a year earlier. Over the last 5 years it ranged from $61.95M to $1.13B, with a median of $484.77M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$606.84M+86.1%
2025Dec 31, 2025$326.11M+84.1%
2024Dec 31, 2024$177.12M+138.2%
2023Dec 29, 2023$74.36M-92.9%
2022Dec 30, 2022$1.05B+18.0%
2021Dec 31, 2021$890.24M+220.6%
2020Dec 31, 2020$277.67M+255.0%
2019Dec 31, 2019$78.21M-65.9%
2018Dec 31, 2018$229.02M-69.9%
2017Dec 29, 2017$760.38M+30.8%
2016Dec 30, 2016$581.45M+690.5%
2015Dec 31, 2015$73.56M–

More Aclaris Therapeutics figures

See a number that looks wrong?